EAM
EXAS

Exome Asset Management’s Exact Sciences EXAS Stock Holding History

Exome Asset Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-26,700
Closed -$1.84M – 60
2024
Q1 		$1.84M Buy
+26,700
New +$1.69M 1.58% 24

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Exome Asset Management's EXAS Position: Q2 2024 in Review

Exome Asset Management sold out of Exact Sciences (EXAS) in Q2 2024, closing a stake of 26,700 shares — an estimated $1.84M sold.

Exome Asset Management first reported a position in EXAS in Q1 2024 and held it in 1 quarter. The position peaked at $1.84M in Q1 2024. 542 funds tracked by Wall St. Rank hold EXAS as of Q2 2024.

  • Exome Asset Management reported no remaining Exact Sciences position as of Q2 2024 after selling out during the quarter.
  • Exome Asset Management sold 26,700 Exact Sciences shares in Q2 2024, an estimated $1.84M.
  • Exome Asset Management first reported a position in Exact Sciences in Q1 2024 and held it in 1 quarter.
  • Exome Asset Management's Exact Sciences position peaked at $1.84M in Q1 2024.
  • 542 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2024.

Based on Exome Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.